Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Abbott Laboratories
ABT · NYSE · Health Care Equipment
$104.48−0.23 (−0.22%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Abbott Laboratories (ABT) · oqro.io/stocks/ABT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Their largest buy since 2019Traded May 7 · filed 42 days later
Since the trade +20.1% · S&P 500 −0.2% · to Nov 18
An Abbott Laboratories director paid $174K out of pocket for Abbott Laboratories shares. 2 other people at Abbott Laboratories bought some too, in the same month. Shares held went up 9% with this purchase.
Their largest buy since 2018Traded Apr 27 · filed 1 day later
Since the trade +12.6% · S&P 500 +2.1% · to Nov 18
An Abbott Laboratories director paid $927K out of pocket for Abbott Laboratories shares. 2 other people at Abbott Laboratories bought some too, in the same month.
1 day before an 8-KTraded Apr 23 · filed 4 days later
Since the trade +13.0% · S&P 500 +3.1% · to Nov 18
The CFO of Abbott Laboratories paid $201K out of pocket for Abbott Laboratories shares. 2 other people at Abbott Laboratories bought some too, in the same month.
First insider buy since Feb 2021Traded Jan 23 · filed 3 days later
Since the trade −2.7% · S&P 500 +5.9% · to Nov 18
The CEO of Abbott Laboratories paid $2.01M out of pocket for Abbott Laboratories shares. 1 other person at Abbott Laboratories bought some too, in the same month. Shares held went up 10% with this purchase.
6 open-market purchases and 11 open-market sales by insiders of ABT between Dec 23, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 21, 2026. The data provider lists the next release for Jan 20, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Mary K Moreland, EXECUTIVE VICE PRESIDENT, Nov 5, 2026, about $406K. Sold 15 days after the company's previous earnings release on 2026-10-21Form 4
John A. Jr. Mccoy, VICE PRESIDENT AND CONTROLLER, Sep 2, 2026, about $3K. Sold 48 days after the company's previous earnings release on 2026-07-16Form 4
Robert B Ford, CHAIRMAN AND CEO, Aug 25, 2026, about $25.3M. Sold 40 days after the company's previous earnings release on 2026-07-16Form 4
Robert B Ford, CHAIRMAN AND CEO, Aug 25, 2026, about $20.9M. Sold 40 days after the company's previous earnings release on 2026-07-16Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
Louis H. Morrone, EXECUTIVE VICE PRESIDENT, Aug 11, 2026, about $643K. Sold 26 days after the company's previous earnings release on 2026-07-16
John G Stratton, Director, May 7, 2026, about $174K. Bought 21 days after the company's previous earnings release on 2026-04-16Form 4
Daniel J Starks, Director, Apr 27, 2026, about $927K. Bought 11 days after the company's previous earnings release on 2026-04-16Form 4
Philip P Boudreau, EVP AND CFO, Apr 23, 2026, about $201K. Bought 7 days after the company's previous earnings release on 2026-04-16Form 4
Eric Shroff, Senior Vice President, Mar 2, 2026, about $82K. Sold 39 days after the company's previous earnings release on 2026-01-22Form 4
Daniel Gesua Sive Salvadori, EVP AND GROUP PRESIDENT, Mar 2, 2026, about $102K. Sold 39 days after the company's previous earnings release on 2026-01-22Form 4